黑料官网

header-logo
Pancreatic Cancer Hero
Pancreatic Cancer

Leading the Way in Discovering Novel Treatments for Pancreatic Cancer

Lytle Micro Group_Image Text Split Component

Commitment to Research

The LaBahn Pancreatic Cancer Program supports internationally recognized specialists who provide a wealth of knowledge and experience in pancreatic cancer treatment and research. We are committed to developing the next generation of medical researchers and to translating our research into cutting-edge treatments for our patients. We are involved in many areas of research, including basic science, outcomes assessments, and international clinical trials. Our dedication to research is one of the many tools we have available to make 黑料官网 a destination for the best pancreatic cancer care possible.

Learn more about our 黑料官网 Pancreas Club

DaveNaveenJenny Freezers_Introcomponent

About our Biorepository

Our biorepository is a phenomenal resource for both translational research collaborations as well as clinical outcomes research. The Ronald Burklund Eich integrated biorepository and database captures longitudinal samples from patients across a broad spectrum of disease, from pancreatic cancer screening to diagnosis, and even post-mortem. 

LEARN MORE ABOUT OUR BIOREPOSITORY

learn more about our RAPID AUTOPSY PROGRAM

Basic and Translational Scientific Investigators

Scientific investigators are discovery-drivers, working to uncover more innovative and cutting-edge treatments with every study they conduct.

headshot

Michael B. Dwinell, PhD

Professor; Founding Director, Center for Immunology; Director, Bobbie Nick Voss Laboratory for Colon Cancer Research; Hanis-Stepka-Rettig Endowed Chair in Cancer Research

Cancer Metastasis, Tumor Microenvironment, Mucosal Inflammation

headshot

Guan Chen, MD, PhD

Professor

headshot

Nikki K. Lytle, PhD

Assistant Professor

headshot

Subramaniam Malarkannan, PhD

Professor and Gardetto Chair for Immunology and Immunotherapy; Professor, Medicine (Hematology and Oncology) and Microbiology & Immunology; Senior Investigator, Versiti Blood Research Institute

NK cell development and function

headshot

Thomas McFall, PhD

Assistant Professor

I am interested in experimental-systems approaches that enable mechanism-based inference in genomic medicine and can help identify patients for selective therapeutic strategies.

headshot

Jong-In Park, PhD

Professor; Eminent Scholar

headshot

Y. David Seo, MD

Assistant Professor

Research Lab Links and More

Recent Publications

  • (Dorbin D, Herrera J, Davidson R, Chandrashekar NK, Scheuber G, Jayakrishnan P, Rajesh C, Johnson G, Yuan J, Sochor M, Langenheim JF, Aldakkak M, Messerly C, Wittmann J, Szabo A, Sayahpour FA, Atallah NL, Peterson FC, Volkman BF, Ali M, Ke E, Evans DB, Tsai S, Lytle NK, Seo YD, Kurzrock R, Hobbs GA, Kamgar M, McFall T.) bioRxiv. 2026 Jul 10 PMID: 42465401 PMCID: PMC13371077 07/17/2026

  • (Milewski D, Fallatah A, Groff M, Rahmy A, Khan SR, Okafor C, Glassberg B, Chou HC, Heselmeyer-Haddad K, Wangsa D, Wangsa D, Kim Y, Isanogle K, Song Y, Zhang X, Thomas C, Difilippantonio S, Park JI, Wei JS, Hawley RG, Glod J, Khan J.) JCO Precis Oncol. 2026 Jun;10(6):e2600091 PMID: 42258786 PMCID: PMC13258109 06/08/2026

  • (Poimenidou M, Bobek JM, Drouillard D, Harris T, Solis E, Darnell C, McAllister D, Keyes RF, Ishihara-Aoki M, Aoki K, Sahoo D, Kalyanaraman B, Smith BC, Dwinell MB.) Cell Death Dis. 2026 May 22;17(1) PMID: 42173830 PMCID: PMC13372815 SCOPUS ID: 2-s2.0-105044729704 05/23/2026

  • (Kamgar M, Hobbes GA, Davidson R, Dorbin D, Herrera J, Langenheim JF, Burge RA, Aldakkak M, Conrardy RD, Szabo A, Thalji SZ, Mayer B, Grahl JJ, Chung BY, Phan A, Thomas JP, Seo YD, Evans DB, Christians KK, Erickson B, Hall WA, George B, Tsai S, Lytle NK, Der CJ, Kurzrock R, McFall T.) Cancer Res. 2026 Apr 15;86(8):2042-2059 PMID: 41134578 PMCID: PMC13080315 SCOPUS ID: 2-s2.0-105031984871 10/24/2025

  • (Burge RA, Le Roux O, Popow O, Spadafora VK, Rajesh C, Adair SJ, Bialousow L, Murphy C, Saberi S, Vaena SG, Taquey MC, Allen S, Han L, Helke KL, Sharma S, Ostrowski MC, Guttridge DC, Dincman TA, Bauer TW, Kashatus DF, McFall T, Haigis KM, Hollingsworth MA, Counter CM, Der CJ, Hobbs GA.) Cancer Res. 2026 Apr 15;86(8):1868-1882 PMID: 41556816 PMCID: PMC13080325 SCOPUS ID: 2-s2.0-105035919044 01/20/2026

  • (Dzikowski M, Pollin G, Gunia V, Butler S, Enkhtuul B, Gavina Chavez J, Zimmermann MT, Mathison A, Urrutia R, Lomberk G.) Front Cell Dev Biol. 2026;14:1748541 PMID: 41890907 PMCID: PMC13013501 SCOPUS ID: 2-s2.0-105033634422 03/27/2026

Publications of , , , , and from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.